Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,499,000) $ (1,386,000)
Adjustments to reconcile net loss to net cash    
Amortization of patents 131,000 104,000
Stock-based compensation 163,000 227,000
Gain on equity investment (1,052,000)
Share of net loss from equity method investment 1,095,000
Deferred tax expense (benefit) 331,000 (232,000)
Amortization of right of use asset 27,000
Unrealized loss (gain) on marketable net securities 1,535,000 (108,000)
Changes in operating assets and liabilities:    
Other current assets 69,000 66,000
Accounts payable 1,114,000 17,000
Operating lease obligations (24,000)
Accrued expenses (314,000) (392,000)
NET CASH USED IN OPERATING ACTIVITIES (1,522,000) (606,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Sales of marketable securities 5,689,000 10,192,000
Purchases of marketable securities (9,053,000) (12,018,000)
Acquisition of patents (250,000) (415,000)
NET CASH USED IN INVESTING ACTIVITIES (3,614,000) (2,241,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends paid (2,315,000) (2,296,000)
Value of shares delivered to fund payment of withholding taxes (9,000) (7,000)
Repurchases of common stock, inclusive of commissions (136,000) (287,000)
NET CASH USED IN FINANCING ACTIVITIES: (2,460,000) (2,590,000)
NET DECREASE IN CASH AND CASH EQUIVALENTS (7,596,000) (5,437,000)
CASH AND CASH EQUIVALENTS, beginning of period 13,402,000 13,145,000
CASH AND CASH EQUIVALENTS, end of period 5,806,000 7,708,000
Cash paid during the period for:    
Interest
Income taxes
NON-CASH FINANCING ACTIVITIES    
Accrued dividend rights on restricted stock units, net of forfeitures (151,000) 51,000
Shares issued for acquisition of patents $ (125,000)